Triall
PrivateLast Round
Grant
Feb 3, 2022
Est. Valuation
$935,312.5
Total Funding Raised
$2.99M
Company Overview
Triall is a healthtech company that provides a digital ecosystem of blockchain-integrated software solutions designed to secure and streamline clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Vertical SaaS, Blockchain Infrastructure, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triall Comparables
Compare Triall with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rymedi | 85% | |
| ClinCapture, Inc. | 81% | |
| Viedoc | 77% | |
Triall Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 3, 2022 | ||||
| Initial Coin Offering | Sep 28, 2021 |
Triall Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mempool Ventures | Initial Coin Offering |
| Dizer capital | Initial Coin Offering |
| Oracles Investment Group | Initial Coin Offering |
| The Kingdom of The Netherlands | Grant |
| CSP DAO | Initial Coin Offering |
| BlackDragon | Initial Coin Offering |
Triall Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Triall's valuation, stock price, and market status.